Where do ARS Pharmaceuticals, Inc.'s ratios come from?

Every ratio is computed from ARS Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-204.5%+8.4pp	-212.9%—	——	——	——
Net margin	-200%+3.2pp	-203.3%-147pp	-56.1%-13.3pp	-42.7%-26.6pp	-16.1%-25.1pp
EBITDA margin	-203%+8.3pp	-211.3%-117pp	-94.5%-2.1pp	-92.5%-18.5pp	-74%-20.0pp
Free cash flow margin	-177.1%+26.0pp	-203.1%-143pp	-60.2%-12.7pp	-47.5%-25.8pp	-21.7%-36.2pp
Returns
Return on equity	-136.4%-44.1pp	-92.3%-46.4pp	-45.9%-22.4pp	-23.6%-16.7pp	-6.9%-10.2pp
Return on assets	-64.4%-13.9pp	-50.5%-23.4pp	-27.1%-9.2pp	-17.9%-12.3pp	-5.6%-8.4pp
Return on invested capital	-125.5%-29.8pp	-95.6%-17.3pp	-78.3%-13.2pp	-65%-24.6pp	-40.4%-15.0pp
Efficiency
Asset turnover	0.3×+0.1×	0.2×-0.2×	0.5×+0.1×	0.4×+0.1×	0.4×0.0×
Liquidity
Current ratio	4.9×-2.3×	7.3×+0.6×	6.7×+0.5×	6.2×-4.8×	11×-3.3×
Quick ratio	4.5×-2.2×	6.7×+0.3×	6.4×+0.5×	5.9×-4.7×	10.6×-3.5×
Cash ratio	0.5×-0.6×	1.1×-0.1×	1.2×0.0×	1.1×-0.3×	1.4×-0.7×
Leverage
Debt-to-equity	1.6×+0.7×	0.8×+0.2×	0.7×+0.7×	0×0.0×	0×0.0×
Debt-to-assets	0.3×0.0×	0.3×0.0×	0.3×+0.3×	0×0.0×	0×0.0×
Per Share
Book value per share	$0.62-46.7%	$1.16-22.4%	$1.49-23.6%	$1.96-16.3%	$2.34-6.9%
Valuation
Market capitalization	$1.05B-48.7%	$1.15B+15.9%	$993.2M-39.7%	$1.65B+33.5%	$1.23B+20.4%
Enterprise value	$1.12B-42.6%	$1.21B+17.0%	$1.03B-35.5%	$1.6B+33.8%	$1.19B+22.6%
Price / sales	10.6×-10.4×	13.7×+6.7×	7×-7.7×	14.7×+2.0×	12.7×+1.2×
Price / book	13×+6.2×	10.1×+3.4×	6.7×-1.8×	8.6×+3.2×	5.4×+1.4×
EV / sales	8.8×-6.8×	14.3×+7.1×	7.2×-7.0×	14.2×+1.9×	12.3×+1.4×
Free cash flow yield	-22%-20.7pp	-14.9%-6.2pp	-8.7%-5.4pp	-3.2%-1.5pp	-1.7%-3.0pp
Earnings yield	-24.9%-23.8pp	-14.9%-6.8pp	-8.1%-5.1pp	-2.9%-1.6pp	-1.3%-2.0pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about ARS Pharmaceuticals, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do ARS Pharmaceuticals, Inc.'s ratios come from?: Every ratio is computed from ARS Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.